Migraine
RecruitingA study to evaluate the effect of rimegepant in patients with migraine and obesity
- Disease:Migraine
- Substances:Rimegepant
Austria- Participants:18–64 years
- Substances:Rimegepant
- Sponsor:Konvent Der Barmherzigen Brueder
Rare diseases
Investigational molecules
Locations
Seilerstaette 2, 4020 Linz, Austria
Clinical research activity is centered on migraine, with attention to treatment response in people affected by this neurological disorder. The funded trial reflects interest in the clinical management of headache burden and factors that may influence therapeutic benefit.
The sponsor’s current research focus includes patient characteristics relevant to migraine care, supporting clinical interest in individualized management within this therapeutic area.
Konvent Der Barmherzigen Brueder runs clinical trials in conditions such as Migraine, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.